|
Regulated Markets
The global generics market is booming and is worth above USD 45bn and continues to grow year on year.
The reasons to name a few are:
Patent expiry for key pharmaceutical drugs over the next coming years.
More and more pro-generic regulatory reforms.
Under penetrated markets like Italy, Spain.
Based on above European generic market expects strong volume growth offering opportunities and challenges.
Today, the generic
products are approved and monitored by regulatory agencies under the
same quality and safety standards as branded products.
To meet the new challanges Erica has embarked and is focused upon transforming:
Product development
Manufacturing
Quality control
Business culture
To maintain growth and profitability with a good understanding of competitive intelligence
Strategic partnering
Mergers and acquisitions
This is a focused strategy to offer affordable prices.
Licensing
Licensing is emerging as a
key value driver. Erica recognises licensing as a strategic mechanism
for the partnering companies to achieve the corporate objectives. Talk
to us, we may have a solution just to suit your dossier and supply
requirements.
Contract Manufacturing
We are experienced in the production of a variety of formulations in
different dosage forms. Erica can help you achieve your clinical and
commercial manufacturing goals. The main advantages of partnering with
us are flexibility, understanding your needs and guaranteed quality.
Semi Regulated Markets
Our product range
comprises of antimalarials, antibacterials and nutritional supplements.
We have more than 100 products registered with regulatory authorities
of various countries and over 150 product registrations are underway.
Some of our important markets are
Nigeria,
Zambia,
Kenya,
DRC,
Guinea,
Vietnam,
Cambodia,
Myanmar and
Srilanka.
Our team of representatives and country managers promote Erica´s products through doctors, distributors and pharmacies.
India
Generics
Indian generics market
according to the latest market research, reports the acceptance and
growth of generic products. We intend to make a significant presence in
this growing segment with our range of products with high packaging
standards and affordable prices.
Institutional tenders
We participate actively
and have been awarded government tenders. To expand our activities we
welcome new partners and distributors.
|